DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 6Strides Pharma Science
03 1Acella Pharmaceuticals
04 13Actavis Inc
05 1Aeon Formulations Private Limited
06 4Ajanta Pharma Limited
07 11Alembic Pharmaceuticals Limited
08 4Amneal Pharmaceuticals
09 1Anwita Drugs & Chemicals Pvt Ltd
10 4Apotex Inc
11 1Aurobindo Pharma Limited
12 7Avet Pharmaceuticals
13 2Bausch & Lomb Incorporated
14 2Changzhou Pharmaceutical Factory
15 9Chartwell Pharmaceuticals llc
16 1DenMat Dental
17 1ENDO OPERATIONS
18 5Epic Pharma. LLC.
19 2Fresenius Kabi USA
20 1GALDERMA LABS LP
21 1GLAND PHARMA LIMITED
22 1Galderma
23 2HALSEY
24 3HEATHER
25 8Hikma Pharmaceuticals
26 1Holden Medical Laboratories Pvt. Ltd
27 2Impax Laboratories
28 3Interpharm
29 2JAMP PHARMA
30 1KINDOS
31 1LABORATOIRE RIVA INC.
32 1LARKEN LABS
33 11Lupin Ltd
34 1MANTRA PHARMA INC
35 2MS Pharma
36 10Mayne Pharma
37 3Mutual Pharmaceutical Company, Inc.
38 1Neopharma
39 2Nesher Pharmaceuticals USA LLC
40 3Nostrum Laboratories
41 1Novel Laboratories, Inc.
42 1ORYZA
43 1PENDOPHARM DIVISION OF DE PHARMASCIENCE INC
44 1PRO DOC LIMITEE
45 2PVT FORM
46 1Pantex Holland
47 2Par Pharmaceutical
48 4Pelcoat Formulations
49 5Pfizer Inc
50 1Pharmanovia A/S
51 1Pharmaris
52 2Pharmascience Inc.
53 1Pliva Hrvatska
54 1Praxgen
55 3Prinston
56 2Qilu Animal Health Products
57 2Quad Pharma
58 1RACHELLE
59 2RANBAXY LABORATORIES LIMITED
60 1Ratiopharm GmbH
61 7Rising Pharmaceuticals Inc
62 2SANIS HEALTH INC
63 3SUPERPHARM
64 2Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
65 2Slate Run Pharmaceuticals
66 4Sun Pharmaceutical Industries Limited
67 5Teva Pharmaceutical Industries
68 2Torrent Pharmaceuticals Limited
69 2Unichem Laboratories Limited
70 2V-Ensure
71 2Viatris
72 1Virjo Healthcare
73 4Warner Chilcott Company, LLC
74 2West-ward Pharmaceutical Corp
75 2Zhejiang Yongtai Technology
76 3Zydus Lifesciences
77 5Zydus Pharmaceuticals
01 9CAPSULE
02 1CAPSULE, COATED PELLETS;ORAL
03 5CAPSULE, DELAYED RELEASE;ORAL
04 53CAPSULE;ORAL
05 1CONCENTRATE FOR SOLUTION FOR INFUSION
06 5Capsule
07 1Capsule IP
08 4Enteric Coated Pellets
09 21INJECTABLE;INJECTION
10 1Inection
11 2Injectable; Injection
12 1Injection
13 1ORAL SUSPENSION
14 1Oral Solution/Suspension
15 1Pellet
16 2Powder
17 1SYSTEM, EXTENDED RELEASE;PERIODONTAL
18 9TABLET
19 42TABLET, DELAYED RELEASE;ORAL
20 57TABLET;ORAL
21 2Tablet
22 1WSP / Premix
23 1Water Soluble Powder
01 101DISCN
02 6Generic
03 15Prescription
04 79RX
05 21Blank
01 2ACTICLATE
02 1ACTICLATE CAP
03 1APO-DOXY CAP 100MG
04 1APO-DOXY TABS 100MG
05 1ATRIDOX
06 9DORYX
07 2DORYX MPC
08 1DOXIEONnn
09 1DOXY 100
10 1DOXY 200
11 3DOXY-LEMMON
12 1DOXYCHEL HYCLATE
13 1DOXYCIN TAB 100MG
14 7DOXYCYCLINE
15 1DOXYCYCLINE CAPSULES
16 146DOXYCYCLINE HYCLATE
17 1DOXYCYCLINE TABLETS
18 1DOXYTAB
19 1Doxyferm
20 1Doxyline-100
21 1Doxyline-200
22 2Doxy®
23 1Gendox 10/5
24 1JAMP DOXYCYCLINE
25 1JAMP DOXYCYCLINE CAPSULES
26 1LYMEPAK
27 1M-DOXYCYCLINE
28 1Neocycline
29 3PERIOSTAT
30 2PMS-DOXYCYCLINE
31 1PRZ-DOXYCYCLINE
32 2TEVA-DOXYCYCLINE
33 1VIBRA-TABS
34 4VIBRAMYCIN
35 1Vibranord
36 16Blank
01 15Canada
02 4China
03 15India
04 2Jordan
05 1Netherlands
06 2Sweden
07 1U.A.E
08 182USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-04-07
Application Number : 62538
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 61717
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 61717
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 62031
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ATRIDOX
Dosage Form : SYSTEM, EXTENDED RELEASE;PERIODONTAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1998-09-03
Application Number : 50751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-30
Application Number : 50744
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-02-02
Application Number : 50783
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-07-22
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2001-08-13
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2008-06-20
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 80MG BASE
Packaging :
Approval Date : 2013-04-11
Application Number : 50795
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2013-04-11
Application Number : 50795
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2014-12-19
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DORYX MPC
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 60MG BASE
Packaging :
Approval Date : 2016-05-20
Application Number : 50795
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX MPC
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 120MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2016-05-20
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRA-TABS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50533
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCHEL HYCLATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 61953
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
